|
DDX6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6479999970519E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8030000048519E-08 |
| Normal-vs-Stage2 |
1.615840E-02 |
| Normal-vs-Stage3 |
3.630500E-04 |
| Normal-vs-Stage4 |
7.69850000000849E-05 |
| Stage1-vs-Stage2 |
5.566600E-01 |
| Stage1-vs-Stage3 |
8.433000E-01 |
| Stage1-vs-Stage4 |
6.861400E-01 |
| Stage2-vs-Stage3 |
5.451200E-01 |
| Stage2-vs-Stage4 |
4.619600E-01 |
| Stage3-vs-Stage4 |
8.012600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.7612000009245E-08 |
| Normal-vs-AfricanAmerican |
4.18760000000518E-05 |
| Normal-vs-Asian |
1.78155999999152E-05 |
| Caucasian-vs-AfricanAmerican |
8.601400E-01 |
| Caucasian-vs-Asian |
2.352600E-01 |
| AfricanAmerican-vs-Asian |
2.150200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.21859999658147E-10 |
| Normal-vs-Female |
2.887500E-02 |
| Male-vs-Female |
3.939400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.794100E-04 |
| Normal-vs-Extreme_Weight |
1.04139999956843E-08 |
| Normal-vs-Obese |
2.397500E-03 |
| Normal-vs-Extreme_Obese |
1.97430000004051E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.615600E-01 |
| Normal_Weight-vs-Obese |
2.500400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.980800E-01 |
| Extreme_Weight-vs-Obese |
2.249700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.360600E-01 |
| Obese-vs-Extreme_Obese |
6.094000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.541800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.441200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.26510024678339E-10 |
| Normal-vs-Age(81-100Yrs) |
1.144800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.461200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.008400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.171770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.556970E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.917500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.773000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.89660000219305E-08 |
| Normal-VS-Type2 PRCC |
1.14110054738603E-10 |
| Normal-VS-KIRP CIMP |
2.233200E-01 |
| Normal-VS-Unclassified PRCC |
1.140830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.837800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.533400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.143200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.347500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.045700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.459200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.15919998442149E-09 |
| Normal-vs-N1 |
1.003580E-02 |
| Normal-vs-N2 |
1.46149999880052E-08 |
| N0-vs-N1 |
6.034400E-02 |
| N0-vs-N2 |
7.313200E-01 |
| N1-vs-N2 |
4.737800E-02 |
|
|
